---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-046508"
form_type: "8-K"
ticker: "SSKN"
cik: "0001051514"
company_name: "STRATA Skin Sciences, Inc."
filed_at: "2024-11-13T23:59:59+00:00"
generated_at: "2026-05-30T00:45:59.526222+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# STRATA Skin Sciences Q3 rev $8.8M, first non-GAAP operating profit since 2018

## Summary
- Revenue $8.8M (-1% YoY); recurring revenue $5.4M (+2% YoY); gross margin 60.3% (up from 56.0% YoY).
- Non-GAAP operating profit $128K (excl. $1.8M NY tax accrual); first since 2018 refinancing.
- Net loss narrowed to $0.3M ($0.08/sh) from $1.1M ($0.30/sh) in Q3 2023; cash $8.4M.
- XTRAC domestic base 873 (down from 882 Q2); TheraClear X base 135 (up from 117 Q2).
- Designated John Gillings (VP Finance) as principal financial & accounting officer; raised $2.1M in July equity offering.

## SEC filing metadata
- accession: 0001140361-24-046508
- form_type: 8-K
- ticker: SSKN
- cik: 0001051514
- company_name: STRATA Skin Sciences, Inc.
- filed_at: 2024-11-13T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1051514/000114036124046508/0001140361-24-046508-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1051514/000114036124046508/ef20038566_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-046508
- JSON: https://secwatch.observer/filing/0001140361-24-046508.json
- Plain text: https://secwatch.observer/filing/0001140361-24-046508.txt

## Key facts
- Executive change
  John Gillings was appointed as principal financial officer and principal accounting officer at STRATA Skin Sciences, Inc..
  - Action: designated
  - Role: principal financial officer and principal accounting officer
  source text: On November 13, 2024, Strata Skin Sciences, Inc. (the “Company”) designated its Vice President Finance, John Gillings, as its principal financial officer and principal accounting officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1051514/000114036124046508/0001140361-24-046508-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.